Back to search

Article

Targeting Thymidine Phosphorylase with Tipiracil Hydrochloride is a Safe and Effective Antithrombotic Therapy

2020-04-27

Abstract excerpt

<h4>Rationale</h4> Most of the current anti-platelet drugs inhibit platelet function permanently and have systemic side effects, including thrombocytopenia and hemorrhage. We previously found that thymidine phosphorylase (TYMP), a platelet cytoplasmic protein, facilitates multiple agonist induced platelet activation and enhances thrombosis. A specific TYMP inhibitor, namely, tipiracil hydrochloride (TPI), has bee...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
0f2c5943-e040-51be-855d-100bd192448b
DOI
10.1101/2020.04.25.061234
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Targeting Thymidine Phosphorylase with Tipiracil Hydrochloride is a Safe and Effective Antithrombotic TherapyDOI 10.1101/2020.04.25.061234
Select a neighboring publication to make it the new centre.